Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MUNICH, GERMANY--(Marketwired - Mar 2, 2016) - One of the biggest obstacles to JV success is managing the partnership once the deal has been signed, according to a new report by The Boston...
-
DALLAS, TX--(Marketwired - Mar 1, 2016) - Michael Sherman, a Dallas-based partner with The Boston Consulting Group (BCG) and a trusted advisor to many of the world's most respected technology...
-
ZURICH, SWITZERLAND--(Marketwired - Mar 1, 2016) - The partners of The Boston Consulting Group (BCG) have elected Zurich-based senior partner Pia Tischhauser as a member of the firm's global...
-
BOSTON, MA--(Marketwired - Feb 25, 2016) - Tech companies have increasingly come under siege by shareholder activists. Yet most tech executives are unprepared to face activists. Concentrating on...
-
NEW YORK, NY--(Marketwired - Feb 24, 2016) - The Boston Consulting Group (BCG) announced today that Laila Worrell has joined the firm as a Partner and Managing Director in its fast-growing...
-
BOSTON, MA--(Marketwired - Feb 23, 2016) - Car sharing is taking hold in large urban areas in both mature and emerging markets, growing rapidly in areas that clear certain social, economic,...
-
MUNICH, GERMANY--(Marketwired - Feb 19, 2016) - Operational improvement has become the main source of value creation in private equity, increasing its share from 18% in the 1980s to 48% in 2012....
-
MUNICH, GERMANY--(Marketwired - Feb 17, 2016) - Few large international nongovernmental organizations (INGOs) have an effective means of measuring long-term impact in the social sector. Working in...
-
SINGAPORE--(Marketwired - Feb 4, 2016) - While emerging markets have driven growth for multinational corporations (MNCs) for years, future performance will be challenged by slower macroeconomic...
-
BOSTON, MA--(Marketwired - Jan 25, 2016) - R&D productivity in the biopharma industry has been notoriously low, except for a few outlier companies. The key differentiator between these high...